SynthesisJournal of perinatology : official journal of the California Perinatal Association2026
Prevention and management of metabolic bone disease of prematurity: a systematic review.
Synthesis in Journal of perinatology : official journal of the California Perinatal Association, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
19 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveMetabolic Bone Disease of Prematurity (MBDP) results from disrupted third-trimester mineral accretion in preterm neonates, leading to inadequate bone mineralization. Despite adherence to standard nutritional guidelines, MBDP remains common. This systematic review assesses the effectiveness of nutritional supplementation and physiotherapy in reducing MBDP incidence and severity. STUDY
designThe review was conducted under PRISMA guidelines and registered with PROSPERO. We retrieved 942 studies from PubMed and Embase. Eligible studies included RCTs/cohort studies published 2020-2025 that investigated postnatal calcium, phosphate, vitamin D supplementation, or physiotherapy in preterm infants (<37 weeks), while recognising that the highest MBDP burden occurs in infants born <32 weeks or with very low birth weight and that selected moderate-to-late preterm infants may remain vulnerable when additional nutritional or clinical risk factors are present. Studies were screened with Covidence, and relevant data were qualitatively synthesized by intervention type and outcomes.
resultsFrom a total of 942 records initially identified, sixteen studies were included (eleven supplementation, five physiotherapy). Higher-dose calcium and organic phosphate, especially when administered continuously, improved biochemical and radiological outcomes. High-dose vitamin D offered no benefit over standard dosing, but individualized monitoring improved safety. Limited evidence demonstrated that active or reflex-based physiotherapy improved bone density and growth but with some concerns for safety; passive approaches had limited effect.
conclusionContinuous high-dose calcium and organic phosphate are particularly beneficial. Standardized diagnostic criteria for biochemical and radiological MBDP assessment are needed, as the absence of consensus disease definitions remains a major barrier to interstudy comparability, evidence synthesis, and the development of clinical intervention protocols. REGISTRATION: This systematic review was prospectively registered with PROSPERO (CRD420251116486).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.